Tumours of Haematopoietic and Lymphoid Tissues

From Compendium of Cancer Genome Aberrations
This is the approved revision of this page, as well as being the most recent.
Jump to navigation Jump to search

Myeloproliferative Neoplasms (MPN) (Overview Page Link)

Mastocytosis (Overview Page Link)

Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 (Overview Page Link)

Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) (Overview Page Link)

Myelodysplastic Syndromes (MDS) (Overview Page Link)

Myeloid Neoplasms with Germline Predisposition (Overview Page Link)

Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms (Overview Page Link)

  - AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1
  - AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
  - Acute Promyelocytic Leukemia (APL) with PML-RARA
  - AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3
  - AML with t(6;9)(p23;q34.1); DEK-NUP214
  - AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM
  - AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1
  - AML with BCR-ABL1
  - AML with Mutated NPM1
  - AML with Biallelic Mutations of CEBPA
  - AML with Mutated RUNX1
  - AML with Minimal Differentiation
  - AML without Maturation
  - AML with Maturation
  - Acute Myelomonocytic Leukemia
  - Acute Monoblastic and Monocytic Leukemia
  - Pure Erythroid Leukemia
  - Acute Megakaryoblastic Leukemia (AMKL)
  - Acute Basophilic Leukemia
  - Acute Panmyelosis with Myelofibrosis
  - Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome
  - Myeloid Leukemia Associated with Down Syndrome

Blastic Plasmacytoid Dendritic Cell Neoplasm (Overview Page Link)

Acute Leukemias of Ambiguous Lineage (MPAL) (Overview Page Link)

  - Acute Undifferentiated Leukemia
  - Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1
  - Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged
  - Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified
  - Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified
  - Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types
  - Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)

Precursor Lymphoid Neoplasms (B-ALL, T-ALL) (Overview Page Link)

  - B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1
  - B-ALL with t(v;11q23.3); KMT2A-Rearranged
  - B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1
  - B-ALL with Hyperdiploidy
  - B-ALL with Hypodiploidy
  - B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3
  - B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1
  - B-ALL, BCR-ABL1-Like
  - B-ALL with iAMP21
  - B-ALL, Not Otherwise Specified
  - Early T-Cell Precursor Lymphoblastic Leukemia
  - NK-Lymphoblastic Leukemia/Lymphoma

Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) (Overview Page Link)

  - Monoclonal B-cell Lymphocytosis
  - Splenic Diffuse Red Pulp Small B-cell Lymphoma
  - Hairy Cell Leukemia Variant
  - Waldenstrom Macroglobulinemia
  - Mu Heavy Chain Disease
  - Gamma Heavy Chain Disease
  - Alpha Heavy Chain Disease
  - Non-IgM Monoclonal Gammopathy of Undetermined Significance
  - Plasma Cell Myeloma
  - Plasma Cell Myeloma Variants
  - Plasmacytoma
  - Monoclonal Immunoglobulin Deposition Diseases
        - Primary Amyloidosis
        - Light Chain and Heavy Chain Deposition Disease
  - Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome
        - POEMS Syndrome
        - TEMPI Syndrome
  - Paediatric Nodal Marginal Zone Lymphoma
  - Testicular Follicular Lymphoma
  - In Situ Follicular Neoplasia
  - Duodenal-Type Follicular Lymphoma
  - Leukemic Non-Nodal Mantle Cell Lymphoma
  - In Situ Mantle Cell Neoplasia
  - Fibrin-Associated Diffuse Large B-cell Lymphoma
  - Multicentric Castleman Disease
  - HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)
  - HHV8-Positive Germinotropic Lymphoproliferative Disorder
  - High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements
  - High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)

Mature T- and NK-cell Neoplasms (Overview Page Link)

  - Systemic EBV-Positive T-cell Lymphoma of Childhood
  - Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form
  - Hydroa Vacciniforme-Like Lymphoproliferative Disorder
  - Severe Mosquito Bite Allergy
  - Enteropathy-Associated T-cell Lymphoma
  - Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
  - Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)
  - Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract
  - Lymphomatoid Papulosis
  - Primary Cutaneous Anaplastic Large Cell Lymphoma
  - Primary Cutaneous Gamma Delta T-cell Lymphoma
  - Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma
  - Primary Cutaneous Acral CD8+ T-cell Lymphoma
  - Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder
  - Angioimmunoblastic T-cell Lymphoma
  - Follicular T-cell Lymphoma
  - Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype

Hodgkin Lymphomas (Overview Page Link)

  - Nodular Sclerosis Classic Hodgkin Lymphoma
  - Lymphocyte-Rich Classic Hodgkin Lymphoma
  - Mixed Cellularity Classic Hodgkin Lymphoma
  - Lymphocyte-Depleted Classic Hodgkin Lymphoma

Immunodeficiency-Associated Lymphoproliferative Disorders (Overview Page Link)

  - Non-Destructive Post-Transplant Lymphoproliferative Disorders
  - Polymorphic Post-Transplant Lymphoproliferative Disorders
  - Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)
        - Monomorphic B-cell PTLD
        - Monomorphic T/NK-cell PTLD
  - Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder

Histiocytic and Dendritic Cell Neoplasms (Overview Page Link)

  - Langerhans Cell Histiocytosis
  - Langerhans Cell Sarcoma
  - Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma

Notes

*The hierarchical tumour classification structure displayed on this page is reproduced from the WHO Classification of Tumours with permission from the copyright holder, ©International Agency for Research on Cancer.